NCT00410956 2024-12-10
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
Peking Union Medical College Hospital
Vanderbilt-Ingram Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)